Pilot Study of Bioequivalence of Cudafol(R) and Diprivan(R) Administered as Single Intravenous Doses in Healthy Subjects

NCT02713802 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: Cudafol(R) (propofol, 1% [10 mg/mL])
DRUG: Diprivan(R) (propofol, 1% [10 mg/mL])

Sponsor

Cuda Anesthetics, LLC